We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kaspien Holdings Inc | NASDAQ:KSPN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.2014 | 0.3015 | 0.3099 | 0 | 01:00:00 |
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
New York
|
14-1541629
|
|
State or Other Jurisdiction of Incorporation or Organization
|
I.R.S. Employer Identification No.
|
|
2818 N. Sullivan Rd. Ste 130
Spokane Valley, WA
|
99216
|
|
Address of Principal Executive Offices
|
Zip Code
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $.01 par value per share
|
KSPN
|
NASDAQ Stock Market |
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
Emerging growth company ☐
|
Form 10-Q
Page No.
|
|
PART I. FINANCIAL INFORMATION
|
|
Item 1 – Interim Condensed Consolidated Financial Statements (Unaudited)
|
|
4
|
|
5
|
|
|
|
6
|
|
|
|
7
|
|
|
|
8
|
|
9 | |
22 | |
30 |
|
30 |
|
PART II. OTHER INFORMATION
|
|
31 | |
31 | |
31 | |
31 | |
31 | |
32 | |
32 |
|
33 |
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
October 29,
|
October 30,
|
October 29,
|
October 30,
|
|||||||||||||
2022 |
2021 | 2022 |
2021 |
|||||||||||||
Net revenue
|
$
|
29,145
|
$
|
32,172
|
$ | 94,843 | $ | 107,680 | ||||||||
Cost of sales
|
22,570
|
24,168
|
74,688 | 81,044 | ||||||||||||
Gross profit
|
6,575
|
8,004
|
20,155 | 26,636 | ||||||||||||
Selling, general and administrative expenses
|
9,255
|
10,018
|
29,975 | 30,886 | ||||||||||||
Loss from operations
|
(2,680
|
)
|
(2,014
|
)
|
(9,820 | ) | (4,250 | ) | ||||||||
Interest expense
|
881
|
439
|
2,544 | 1,455 | ||||||||||||
Other income |
- | (1,567 | ) | - | (3,530 | ) | ||||||||||
Loss before income tax expense
|
(3,561
|
)
|
(886
|
)
|
(12,364 | ) | (2,175 | ) | ||||||||
Income tax expense
|
-
|
-
|
43 | 46 | ||||||||||||
Net loss
|
$ |
(3,561
|
)
|
$ |
(886
|
)
|
$ |
(12,407 | ) | $ |
(2,221 | ) | ||||
BASIC AND DILUTED LOSS PER SHARE:
|
||||||||||||||||
Basic and diluted loss per common share
|
$ | (0.92 | ) | $ | (0.36 | ) | $ | (4.15 | ) | $ | (0.92 | ) | ||||
Weighted average number of common shares outstanding – basic and diluted
|
3,865 | 2,491 | 2,990 | 2,404 |
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended |
|||||||||||||||
October 29,
|
October 30,
|
October 29,
|
October 30,
|
|||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Net loss
|
$
|
(3,561
|
)
|
$
|
(886
|
)
|
$ | (12,407 | ) | $ | (2,221 | ) | ||||
Amortization of pension gain
|
-
|
-
|
- | - | ||||||||||||
Comprehensive loss
|
$
|
(3,561
|
)
|
$
|
(886
|
)
|
$ | (12,407 | ) | $ | (2,221 | ) |
Thirteen Weeks Ended October 29, 2022 | ||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
|
Retained
|
||||||||||||||||||||||||||||||
Additional
|
Treasury
|
Other
|
Earnings
|
|||||||||||||||||||||||||||||
Common
|
Treasury
|
Common
|
Paid-in
|
Stock
|
Comprehensive
|
(Accumulated
|
Shareholders’
|
|||||||||||||||||||||||||
Shares
|
Shares
|
Stock
|
Capital
|
At Cost
|
Loss
|
Deficit)
|
Equity
|
|||||||||||||||||||||||||
Balance as of July 30, 2022
|
3,912
|
(772
|
)
|
$
|
39
|
$
|
263,723
|
$
|
(125,906
|
)
|
$
|
(910
|
)
|
$
|
(129,740
|
)
|
$
|
7,206
|
||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,561
|
)
|
(3,561
|
)
|
||||||||||||||||||||||
Issuance of shares, net of expenses
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
Exercise of warrants |
1,403 | 305 | 14 | (49,788 | ) | 49,774 | - | - | - | |||||||||||||||||||||||
Common stock issued-Restricted share units
|
7
|
-
|
-
|
1
|
-
|
-
|
-
|
1
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
57
|
-
|
-
|
-
|
57
|
||||||||||||||||||||||||
Balance as of October 29, 2022
|
5,322
|
|
(467
|
)
|
$
|
53
|
$
|
213,992
|
$
|
(76,132
|
)
|
$
|
(910
|
)
|
$
|
(133,301
|
)
|
$
|
3,702
|
Thirty-Nine Weeks Ended October 29, 2022
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
|
Retained
|
||||||||||||||||||||||||||||||
Additional
|
Treasury
|
Other
|
Earnings
|
|||||||||||||||||||||||||||||
Common
|
Treasury
|
Common
|
Paid-in
|
Stock
|
Comprehensive
|
(Accumulated
|
Shareholders’
|
|||||||||||||||||||||||||
Shares
|
Shares
|
Stock
|
Capital
|
At Cost
|
Loss
|
Deficit)
|
Equity
|
|||||||||||||||||||||||||
Balance as of January 29, 2022
|
3,903
|
(1,410
|
)
|
$
|
39
|
$
|
359,220
|
$
|
(230,170
|
)
|
$
|
(910
|
)
|
$
|
(120,894
|
)
|
$
|
7,285
|
||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(12,407
|
)
|
(12,407
|
)
|
||||||||||||||||||||||
Issuance of shares, net of expenses
|
-
|
638
|
-
|
(97,127
|
)
|
104,264
|
-
|
-
|
7,137
|
|||||||||||||||||||||||
Issuance of warrants
|
-
|
-
|
-
|
1,518
|
-
|
-
|
-
|
1,518
|
||||||||||||||||||||||||
Exercise of warrants
|
1,403
|
305
|
14
|
(49,788
|
)
|
49,774
|
-
|
-
|
-
|
|||||||||||||||||||||||
Vested restricted of shares |
7 | - | - | 1 | - | - | - | 1 | ||||||||||||||||||||||||
Common stock issued- Director grants
|
9
|
-
|
-
|
41
|
-
|
-
|
-
|
41
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
128
|
-
|
-
|
-
|
128
|
||||||||||||||||||||||||
Balance as of October 29, 2022
|
5,322
|
(467
|
)
|
$
|
53
|
$
|
213,992
|
$
|
(76,132
|
)
|
$
|
(910
|
)
|
$
|
(133,301
|
)
|
$
|
3,702
|
Thirteen Weeks Ended October 30,
2021
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
|
Retained
|
||||||||||||||||||||||||||||||
Additional
|
Treasury
|
Other
|
Earnings
|
|||||||||||||||||||||||||||||
Common
|
Treasury
|
Common
|
Paid-in
|
Stock
|
Comprehensive
|
(Accumulated
|
Shareholders’
|
|||||||||||||||||||||||||
Shares
|
Shares
|
Stock
|
Capital
|
At Cost
|
Loss
|
Deficit)
|
Equity
|
|||||||||||||||||||||||||
Balance as of July 31, 2021
|
3,903
|
(1,410
|
)
|
$
|
39
|
$
|
359,016
|
$
|
(230,170
|
)
|
$
|
(2,007
|
)
|
$
|
(114,198
|
)
|
$
|
12,680
|
||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(886
|
)
|
(886
|
)
|
||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
84
|
-
|
-
|
-
|
84
|
||||||||||||||||||||||||
Balance as of October 30, 2021
|
3,903
|
|
(1,410
|
)
|
$
|
39
|
$
|
359,100
|
$
|
(230,170
|
)
|
$
|
(2,007
|
)
|
$
|
(115,084
|
)
|
$
|
11,878
|
Thirty-Nine Weeks Ended October 30, 2021
|
||||||||||||||||||||||||||||||||
Number of shares outstanding
|
Accumulated
|
Retained
|
||||||||||||||||||||||||||||||
Additional
|
Treasury
|
Other
|
Earnings
|
|||||||||||||||||||||||||||||
Common
|
Treasury
|
Common
|
Paid-in
|
Stock
|
Comprehensive
|
(Accumulated
|
Shareholders’
|
|||||||||||||||||||||||||
Shares
|
Shares
|
Stock
|
Capital
|
At Cost
|
Loss
|
Deficit)
|
Equity
|
|||||||||||||||||||||||||
Balance as of January 30, 2021
|
3,337
|
(1,410
|
)
|
$
|
33
|
$
|
346,495
|
$
|
(230,169
|
)
|
$
|
(2,007
|
)
|
$
|
(112,863
|
)
|
$
|
1,489
|
||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,221
|
)
|
(2,221
|
)
|
||||||||||||||||||||||
Issuance of warrants
|
138
|
-
|
2
|
- |
(1
|
)
|
-
|
-
|
1
|
|||||||||||||||||||||||
Sales of shares, net of expense
|
417
|
-
|
4
|
12,227
|
-
|
-
|
-
|
12,231
|
||||||||||||||||||||||||
Exercise of stock options
|
2
|
- |
-
|
51
|
-
|
-
|
-
|
51
|
||||||||||||||||||||||||
Common stock issued- Director grants
|
9
|
-
|
-
|
184
|
-
|
-
|
-
|
184
|
||||||||||||||||||||||||
Amortization of unearned compensation/restricted stock amortization
|
-
|
-
|
-
|
143
|
-
|
-
|
-
|
143
|
||||||||||||||||||||||||
Balance as of October 30, 2021
|
3,903
|
|
(1,410
|
)
|
$
|
39
|
$
|
359,100
|
$
|
(230,170
|
)
|
$
|
(2,007
|
)
|
$
|
(115,084
|
)
|
$
|
11,878
|
Thirty-nine Weeks Ended |
||||||||
October 29,
|
October 30,
|
|||||||
2022 |
2021 |
|||||||
OPERATING ACTIVITIES:
|
||||||||
Net loss
|
$
|
(12,407
|
)
|
$
|
(2,221
|
)
|
||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Depreciation of fixed assets
|
961
|
1,064
|
||||||
Amortization of intangible assets
|
-
|
732
|
||||||
Stock-based compensation
|
169
|
327
|
||||||
Amortization of ROU asset
|
466
|
458
|
||||||
Amortization of warrant interest
|
766 | 191 | ||||||
Interest on long term debt
|
849 | 570 | ||||||
Change in cash surrender value
|
591
|
(557
|
)
|
|||||
Forgiveness of PPP Loan
|
- | (1,963 | ) | |||||
Changes in operating assets and liabilities that provide (use) cash:
|
||||||||
Accounts receivable
|
(461
|
)
|
150
|
|||||
Merchandise inventory
|
(8,075
|
)
|
(5,732
|
)
|
||||
Prepaid expenses and other current assets
|
(56
|
)
|
(196
|
)
|
||||
Other long-term assets
|
283
|
268
|
||||||
Accounts payable
|
6,377
|
(2,150
|
)
|
|||||
Accrued expenses and other current liabilities
|
(706
|
)
|
236
|
|||||
Other long-term liabilities
|
(951
|
)
|
(1,167
|
)
|
||||
Net cash used in operating activities
|
(12,194
|
)
|
(9,990
|
)
|
||||
INVESTING ACTIVITIES:
|
||||||||
Purchases of fixed assets
|
(766 | ) | (1,046 | ) | ||||
Net cash provided by (used in) investing activities
|
(766 | ) | (1,046 | ) | ||||
FINANCING ACTIVITIES:
|
||||||||
Proceeds from long term borrowings
|
5,000
|
-
|
||||||
Proceeds from issuance of shares, net of expense
|
7,137 | 12,231 | ||||||
Proceeds from exercise of stock options
|
- | 51 | ||||||
Payments of PPP loan
|
- | (76 | ) | |||||
Payment of short term borrowings
|
(9,966 | ) | (6,339 | ) | ||||
Payments of long term borrowings
|
-
|
(1,600
|
)
|
|||||
Proceeds from short term borrowings
|
9,494 | 5,858 | ||||||
Net cash provided by (used in) financing activities
|
11,665
|
10,125
|
||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash
|
(1,295
|
)
|
(911
|
)
|
||||
Cash, cash equivalents, and restricted cash, beginning of period
|
4,823
|
6,555
|
||||||
Cash, cash equivalents, and restricted cash, end of period
|
$
|
3,528
|
$
|
5,644
|
||||
Supplemental disclosures and non-cash investing and financing activities: |
||||||||
Interest paid |
$ | 461 | $ | 295 | ||||
Warrants issued with debt |
$ | 1,633 | $ | - |
•
|
We are partner obsessed. Our customers are our partners. Every decision is focused on building mutually beneficial relationships that deliver results.
|
•
|
We are insights driven. We make data actionable. Our curiosity drives us to discover opportunities early and often.
|
•
|
We create simplicity. We challenge the status quo. We take the complicated and simplify it.
|
•
|
We take ownership. We make things happen. We hold ourselves accountable and have a bias for action.
|
•
|
We empower each other. We welcome and learn from diverse experiences. Our empathy ignites innovation and empowers meaningful change.
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
|
October 29,
|
October 30,
|
October 29,
|
October 30,
|
||||||||||||
(amounts in thousands)
|
2022 |
2021 |
2022 |
2021 |
||||||||||||
Amortized intangible assets:
|
||||||||||||||||
Technology
|
$
|
-
|
$
|
65
|
$
|
-
|
$
|
259
|
||||||||
Trade names and trademarks
|
-
|
153
|
-
|
473
|
||||||||||||
Total amortization expense
|
$
|
-
|
$
|
218
|
$
|
-
|
$
|
732
|
October 29,
|
January 29,
|
October 30,
|
||||||||||
2022 | 2022 |
2021 |
||||||||||
Cash and cash equivalents
|
$
|
769
|
$
|
1,218
|
$
|
1,754
|
||||||
Restricted cash
|
2,759
|
3,605
|
3,890
|
|||||||||
Total cash, cash equivalents and restricted cash
|
$
|
3,528
|
$
|
4,823
|
$
|
5,644
|
Employee Stock Award Plans
|
||||||||||||||||||||
Number of
Shares
Subject To
Option
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term
|
Other
Share
Awards (1) |
Weighted
Average
Grant Fair
Value
|
||||||||||||||||
Balance January 29, 2022
|
85,965
|
$
|
13.41
|
7.5
|
90,000 |
$ | 15.39 | |||||||||||||
Granted
|
21,750
|
5.57
|
9.9
|
9,000 | 4.59 | |||||||||||||||
Forfeited
|
(20,045
|
)
|
9.31
|
9.1
|
(63,500 | ) | 14.08 | |||||||||||||
Canceled
|
(17,306
|
)
|
15.56
|
-
|
- | - | ||||||||||||||
Exercised
|
-
|
-
|
-
|
(12,000 | ) | 10.77 | ||||||||||||||
Balance October 29, 2022
|
70,364
|
$
|
10.23
|
7.6
|
23,500 | $ | 17.69 | |||||||||||||
Exercisable October 29, 2022
|
25,294
|
$
|
18.70
|
6.2
|
- | $ | - |
Exercise
|
Number
|
|||
Price
|
Outstanding
|
|||
$
|
0.001
|
109,416
|
||
$
|
0.01
|
327,539
|
||
$
|
0.125
|
2,457,160
|
||
2,894,115
|
Thirteen Weeks Ended
|
Thirty-nine Weeks Ended
|
|||||||||||||||
(amounts in thousands)
|
October 29,
|
October 30,
|
October 29,
|
October 30,
|
||||||||||||
|
2022 |
2021 |
2022 |
2021 |
||||||||||||
|
$
|
89
|
$
|
63
|
$
|
267
|
$
|
189
|
||||||||
Net periodic pension cost
|
$
|
89
|
$
|
63
|
$
|
267
|
$
|
189
|
• |
We are partner obsessed. Our customers are our partners. Every decision is focused on building mutually beneficial relationships that deliver results.
|
• |
We are insights driven. We make data actionable. Our curiosity drives us to discover opportunities early and often.
|
• |
We create simplicity. We challenge the status quo. We take the complicated and simplify it.
|
• |
We take ownership. We make things happen. We hold ourselves accountable and have a bias for action.
|
• |
We empower each other. We welcome and learn from diverse experiences. Our empathy ignites innovation and empowers meaningful change.
|
Thirteen Weeks Ended
|
Change
|
Thirty-Nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||||
(amounts in thousands)
|
October 29,
2022
|
October 30,
2021
|
$ |
|
%
|
October 29,
2022
|
October 30,
2021
|
$ |
|
%
|
||||||||||||||||||||||
Net Revenue
|
$
|
29,145
|
$
|
32,172
|
$
|
(3,027
|
)
|
-9.4
|
%
|
$
|
94,843
|
$
|
107,680
|
$
|
(12,837
|
)
|
-11.9
|
%
|
||||||||||||||
Gross profit
|
6,575
|
8,004
|
(1,429
|
)
|
-17.9
|
%
|
20,155
|
26,636
|
(6,481
|
)
|
-24.3
|
%
|
||||||||||||||||||||
% to sales
|
22.6
|
%
|
24.9
|
%
|
21.3
|
%
|
24.7
|
%
|
Thirteen weeks ended
|
Thirty-nine weeks ended
|
|||||||||||||||||||||||||||||||||||||||
October 29, 2022
|
October 30, 2021
|
Change
|
October 29, 2022
|
October 30, 2021
|
Change
|
|||||||||||||||||||||||||||||||||||
Amazon US
|
$
|
27,883
|
95.7
|
%
|
$
|
30,423
|
94.6
|
%
|
-8.3
|
%
|
$
|
89,480
|
94.3
|
%
|
$
|
100,581
|
93.4
|
%
|
-11.0
|
%
|
||||||||||||||||||||
Amazon International
|
528
|
1.8
|
%
|
738
|
2.3
|
%
|
-28.5
|
%
|
2,807
|
3.0
|
%
|
4,295
|
4.0
|
%
|
-34.6
|
%
|
||||||||||||||||||||||||
Other Marketplaces
|
350
|
1.2
|
%
|
543
|
1.7
|
%
|
-35.5
|
%
|
1,131
|
1.2
|
%
|
1,428
|
1.3
|
%
|
-20.8
|
%
|
||||||||||||||||||||||||
Subtotal Retail as a Service
|
28,761
|
98.7
|
%
|
31,704
|
98.5
|
%
|
-9.3
|
%
|
93,418
|
98.5
|
%
|
106,304
|
98.7
|
%
|
-12.1
|
%
|
||||||||||||||||||||||||
Subscriptions
|
384
|
1.3
|
%
|
468
|
1.5
|
%
|
-17.9
|
%
|
1,425
|
1.5
|
%
|
1,376
|
1.3
|
%
|
3.6
|
%
|
||||||||||||||||||||||||
Net revenue
|
$
|
29,145
|
100.0
|
%
|
$
|
32,172
|
100.0
|
%
|
-9.4
|
%
|
$
|
94,843
|
100.0
|
%
|
$
|
107,680
|
100.0
|
%
|
-11.9
|
%
|
Thirteen Weeks Ended
|
Change
|
Thirty-nine Weeks
|
Change
|
|||||||||||||||||||||||||||||
(amounts in thousands)
|
October 29,
2022
|
October 30,
2021
|
$ |
|
%
|
October 29,
2022
|
October 30,
2021
|
$ |
|
%
|
||||||||||||||||||||||
Merchandise margin
|
$
|
12,691
|
$
|
14,653
|
$
|
(1,962) |
-13.4 |
% |
$
|
40,858
|
$
|
49,309
|
$
|
(8,451) |
-17.1
|
%
|
||||||||||||||||
% of net revenue
|
43.5
|
%
|
45.5
|
%
|
-2.0
|
%
|
43.1
|
%
|
45.8
|
%
|
-2.7
|
%
|
||||||||||||||||||||
Fulfillment fees
|
(3,888
|
)
|
(4,375
|
)
|
487
|
-11.1 |
% |
(13,110
|
)
|
(16,218
|
)
|
3,108
|
-19.2
|
%
|
||||||||||||||||||
Warehousing and freight
|
(2,228
|
)
|
(2,274
|
)
|
46
|
-2.0
|
%
|
(7,593
|
)
|
(6,455
|
)
|
(1,138) |
17.6
|
%
|
||||||||||||||||||
Gross profit
|
$
|
6,575
|
$
|
8,004
|
$
|
(1,429) |
-17.9 |
% |
$
|
20,155
|
$
|
26,636
|
$
|
(6,481) |
-24.3
|
%
|
||||||||||||||||
% of net revenue
|
22.6
|
%
|
24.9
|
%
|
21.3
|
%
|
24.7
|
%
|
Thirteen Weeks Ended
|
Change
|
Thirty-Nine Weeks Ended
|
Change
|
|||||||||||||||||||||||||||||
(amounts in thousands)
|
October 29,
2022
|
October 30,
2021
|
$ |
|
%
|
October 29,
2022
|
October 30, 2021
|
$ |
|
%
|
||||||||||||||||||||||
Selling expenses
|
$
|
4,206
|
$
|
4,580
|
$
|
(374
|
)
|
-8.2
|
%
|
$
|
13,683
|
$
|
15,571
|
$
|
(1,888
|
)
|
-12.1
|
%
|
||||||||||||||
General and administrative expenses
|
5,049
|
5,438
|
(389
|
)
|
-7.2
|
%
|
16,292
|
15,315
|
977
|
6.4
|
%
|
|||||||||||||||||||||
Total SG&A expenses
|
$
|
9,255
|
$
|
10,018
|
$
|
(763
|
)
|
-7.6
|
%
|
$
|
29,975
|
$
|
30,886
|
$
|
(911
|
)
|
-2.9
|
%
|
||||||||||||||
As a % of total revenue
|
31.8
|
%
|
31.1
|
%
|
31.6
|
%
|
28.7
|
%
|
As of or for the
Thirty-nine Weeks Ended
|
Change | |||||||||||||
(amounts in thousands)
|
October 29,
2022
|
October 30,
2021
|
$ | |||||||||||
Operating Cash Flows
|
$
|
(12,193
|
)
|
$
|
(9,990
|
)
|
$
|
(2,203
|
)
|
|||||
Investing Cash Flows
|
(766
|
)
|
(1,046
|
)
|
280
|
|||||||||
Financing Cash Flows
|
11,666
|
10,125
|
1,541
|
|||||||||||
Capital Expenditures(1)
|
(766
|
)
|
(1,046
|
)
|
280
|
|||||||||
Cash, Cash Equivalents, and Restricted Cash
|
(2)
|
3,528
|
5,644
|
(2,116
|
)
|
|||||||||
Merchandise Inventory (2)
|
37,353
|
30,248
|
7,105
|
|||||||||||
(1)
|
Included in Investing Cash Flows
|
|||||||||||||
(2)
|
Cash and cash equivalents per condensed consolidated balance sheets
|
$
|
769
|
$
|
1,754
|
$
|
(985
|
)
|
||||||
Add: restricted cash
|
2,759
|
3,890
|
(1,131
|
)
|
||||||||||
Cash, cash equivalents, and restricted cash
|
$
|
3,528
|
$
|
5,644
|
$
|
(2,116
|
)
|
(A) |
Exhibits -
|
Exhibit No.
|
Description
|
Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
Certification pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
XBRL Instance Document (furnished herewith)
|
101.SCH
|
XBRL Taxonomy Extension Schema (furnished herewith)
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase (furnished herewith)
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase (furnished herewith)
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase (furnished herewith)
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase (furnished herewith)
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
|
KASPIEN HOLDINGS INC.
|
||
December 13, 2022
|
By: /s/ Brock Kowalchuk
|
|
Brock Kowalchuk
|
||
Principal Executive Officer
|
||
(Principal Executive Officer)
|
December 13, 2022
|
By: /s/ Edwin Sapienza
|
|
Edwin Sapienza
|
||
Chief Financial Officer
|
||
(Principal and Chief Accounting Officer)
|
1 Year Kaspien Chart |
1 Month Kaspien Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions